It has also been reported that reduced CD4+FoxP3+ Tregs are present in COVID-19, but an increased frequency of TIGIT+ Tregs at the time of hospital admission, which correlates with severity, suggesting that a robust suppressive activity is associated with fatal outcomes (58). This evidence concerns the gene CD4 and COVID-19.